After a few mixed years in medical technology (MedTech) mergers and acquisition (M&A) activity, 2025 is shaping up to be a landmark year, particularly among cash-rich medical device strategics. In Q1 2025, there were 57 MedTech M&A transactions totaling $9.2 billion, compared to 62 deals worth $2.7 billion…
Continue Reading
While Epic UGM 2025 dominated the headlines and most conversations centered around ambient listening and generative AI in clinical workflows, several other important developments in digital health deserve your attention.In this edition of the…
Continue Reading
While Epic UGM 2025 dominated the headlines and most conversations centered around ambient listening and generative AI in clinical workflows, several other important developments in digital health deserve your attention.In this edition of the…
Continue Reading
We're excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. My guest today is Miha Štajdohar, Co-Founder and CTO at Genialis. Genialis develops and markets an…
Continue Reading
Emphysema progression in chronic obstructive pulmonary disease (COPD) presents a notable challenge due to its significant variability among individuals and the current lack of reliable prognostic markers. Given the limited therapeutic options available for…
Continue Reading
Introduction to AI-Powered Mental Health Journaling
Grow Therapy, a leading hybrid mental health provider, has launched an innovative AI-powered journaling feature designed to enhance patient engagement between therapy sessions. This groundbreaking development represents the company’s…
Thomas Kluz, Managing Director at Niterra Ventures
The most consequential shift in modern medicine isn’t happening inside hospitals or biotech labs. It’s happening inside medical simulation labs / training centers.
Drug development has long been marked…
Continue Reading
News
OpenAI says that its newly released GPT-5 is its best model yet for answering health questions as an “active thought partner,” offering improved explanations of test results and health risks, better understanding of medical…
Continue Reading
Dan Cohen, President and Cofounder of Adhere+
The COVID-19 pandemic catalyzed a rapid and necessary transformation in the delivery of healthcare services, especially for vulnerable populations with opioid use disorder (OUD). Regulatory flexibilities introduced during…
Continue Reading
Mark Matson, Senior Director, Sensor Cloud at Medidata
Clinical trials are the foundation of drug development, generating life-saving medicines for the betterment of society. But trials can be arduous, lengthy, and expensive for patients, sites,…
Continue Reading
